Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for obsessive symptoms in bipolar disorder
IRCT20251110067944N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pregabalin in bipolar disorder (BD) and obsessive compulsive disorder (OCD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Dec 2025; status: completed.
02
Drugs
pregabalin
03
Conditions
bipolar disorder (BD)obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20251110067944N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251110067944N1.